Increased Peak Width of Skeletonized Mean Diffusivity in Status Epilepticus: Implication for Diffuse White Matter Microstructural Alteration.
Saved in:
| Title: | Increased Peak Width of Skeletonized Mean Diffusivity in Status Epilepticus: Implication for Diffuse White Matter Microstructural Alteration. |
|---|---|
| Authors: | Kim, Jinseung (AUTHOR), Lee, Dong Ah. (AUTHOR), Lee, Ho-Joon (AUTHOR), Park, Kang Min (AUTHOR), Dhoundiyal, Ankit (AUTHOR) |
| Source: | Acta Neurologica Scandinavica. 5/6/2026, Vol. 2026, p1-7. 7p. |
| Subjects: | Status epilepticus, Biomarkers, Diffusion tensor imaging, Magnetic resonance imaging, Cerebral small vessel diseases, Computer-assisted image analysis (Medicine), Leukoencephalopathies, Brain imaging |
| Abstract: | Objectives: Peak width of skeletonized mean diffusivity (PSMD) serves as a new biomarker for diffuse white matter microstructural damage. This study is aimed at quantifying PSMD in patients with status epilepticus (SE) to investigate white matter microstructural abnormalities and their potential association with small vessel disease (SVD) mechanisms in SE. Methods: We retrospectively enrolled patients with SE and healthy controls matched for age and sex. Diffusion tensor imaging (DTI) was performed using a 3.0 Tesla magnetic resonance imaging scanner to measure PSMD. We compared the PSMD values between patients with SE and healthy controls. Additionally, we analyzed correlations between PSMD and clinical factors in patients with SE. Results: Twenty‐eight patients with SE and 31 healthy controls were included in this study. PSMD values were significantly higher in patients with SE compared with controls (3.024 vs. 2.257, p < 0.001). Additionally, in patients with SE, PSMD positively correlated with age (r = 0.721, p < 0.001). However, PSMD was not significantly correlated with other clinical characteristics, including the duration of SE and the number of antiseizure medications (r = 0.031, p = 0.876; r = −0.340, p = 0.076, respectively). Conclusion: Patients with SE exhibited significantly elevated PSMD, which was associated with white matter microstructural abnormalities. These findings suggested that PSMD may be a useful imaging marker for assessing white matter changes in SE and warrant further investigation into its association with underlying vascular and nonvascular mechanisms. [ABSTRACT FROM AUTHOR] |
| Copyright of Acta Neurologica Scandinavica is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
| Abstract: | Objectives: Peak width of skeletonized mean diffusivity (PSMD) serves as a new biomarker for diffuse white matter microstructural damage. This study is aimed at quantifying PSMD in patients with status epilepticus (SE) to investigate white matter microstructural abnormalities and their potential association with small vessel disease (SVD) mechanisms in SE. Methods: We retrospectively enrolled patients with SE and healthy controls matched for age and sex. Diffusion tensor imaging (DTI) was performed using a 3.0 Tesla magnetic resonance imaging scanner to measure PSMD. We compared the PSMD values between patients with SE and healthy controls. Additionally, we analyzed correlations between PSMD and clinical factors in patients with SE. Results: Twenty‐eight patients with SE and 31 healthy controls were included in this study. PSMD values were significantly higher in patients with SE compared with controls (3.024 vs. 2.257, p < 0.001). Additionally, in patients with SE, PSMD positively correlated with age (r = 0.721, p < 0.001). However, PSMD was not significantly correlated with other clinical characteristics, including the duration of SE and the number of antiseizure medications (r = 0.031, p = 0.876; r = −0.340, p = 0.076, respectively). Conclusion: Patients with SE exhibited significantly elevated PSMD, which was associated with white matter microstructural abnormalities. These findings suggested that PSMD may be a useful imaging marker for assessing white matter changes in SE and warrant further investigation into its association with underlying vascular and nonvascular mechanisms. [ABSTRACT FROM AUTHOR] |
|---|---|
| ISSN: | 00016314 |
| DOI: | 10.1155/ane/7155788 |
